Primary Menu

A panel of CDC advisers will meet Friday to discuss what to do about Johnson & Johnson’s COVID-19 vaccine.

The vaccine was ‘paused’ earlier this month after reports of rare but potentially serious blood clot issues.

The committee met last week but decided more information was needed.

“CDC scientists can make an estimate of what the benefit-risk analysis would be, and that’s certainly going to inform us in our decision,” said Romero, Chair of the CDC’s Advisory Committee on Immunization Practices. “Whoever uses the vaccine — as with any vaccine in this country — they should be informed about any risks associated with it.”

Friday’s meeting could end with the committee recommending the vaccine continue, or halted completely.

For more information, click here. 

Katherine Viloria is Beasley Media Group's Fort Myers Digital Content Manager. She loves to write, snap photos, and watch Grey's Anatomy. Connect with her on Instagram @alittlethisalittlekat